WO2002022864A1 - The method of detecting mutant dspp gene of hereditary opalescent - Google Patents
The method of detecting mutant dspp gene of hereditary opalescent Download PDFInfo
- Publication number
- WO2002022864A1 WO2002022864A1 PCT/CN2000/000280 CN0000280W WO0222864A1 WO 2002022864 A1 WO2002022864 A1 WO 2002022864A1 CN 0000280 W CN0000280 W CN 0000280W WO 0222864 A1 WO0222864 A1 WO 0222864A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dspp
- primer
- gene
- detecting
- mutant gene
- Prior art date
Links
- 0 *C(*CC(CCC(C(*)O)=C)COC(*)Cl)O Chemical compound *C(*CC(CCC(C(*)O)=C)COC(*)Cl)O 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Definitions
- the invention relates to a method for detecting a mutant gene dspp of hereditary opalescent dentin, and the method may be a direct sequencing method or a restriction enzyme method or an oligonucleotide probe hybridization method. More specifically, the present invention is a method for locating the mutation site of the hereditary opalescent tooth shield at the third exon of dspp. In addition, the present application also relates to a kit prepared according to the method of the present invention and the application of the kit to a method for detecting and treating hereditary opalescent dentin. Background technique
- Hereditary opalescent dentin is an autosomal dominant hereditary disease with an incidence of 1/8000. In 1973, Shields classified it as Type 2 dentinogenesis imperfect type 11 (Dentinogenesis Imperfect Type 11). Both the primary and permanent teeth of the patient were affected, and the affected teeth were gray-blue or dark brown with a milky gloss. Under the X-ray film, you can see that the crown is spherical, the roots are smaller, the pulp chamber and root canal are narrowed or completely closed.
- the pathogenic genes of hereditary opalescent dentin have been located in the 2 MB range on 4q21, and within this range 4 genes have been found to be involved in tissue mineralization. They are secreted phosphoprotein 1, SSPl, dentin matrix protein 1, DMPl, dentin sialophosphoprotein (DSPP) and bone saliva. Acid protein (bone sialoprotein, IBSP).
- SSPl secreted phosphoprotein 1
- DMPl dentin matrix protein
- DSPP dentin sialophosphoprotein
- IBSP Acid protein
- the dspp genome sequence was recently determined (AF163151). dspp encodes DSP and DPP 2 proteins, of which DPP Highly phosphorylated, which is thought to regulate the shape and size of hydroxyapatite crystals, and plays an important role in the nucleation process of hydroxyapatite crystals.
- the pathogenic gene of the family used in the present invention is mapped to chromosome 4q by linkage analysis. Then determine the genomic sequence of the first 4 exons of the candidate gene dspp in the patient and compare them with the normal control. It was found that there is a nonsense mutation in the third exon of dspp, so that the present invention finds heredity
- the pathogenic gene of opalescent dentin is dspp. Since this mutation leads to a change in the recognition site of the restriction enzyme Rsal, this method provides convenience for detecting hereditary opalescent dentinopathy. And the invention lays a foundation for further research on the mineralization process of teeth and the pathogenic mechanism and treatment of hereditary opalescent dentin.
- the present invention finds that the dspp gene is a disease-causing gene of hereditary opalescent dentin, which is the premise for further searching for other pathogenic mutations of the dspp gene in more hereditary opalescent dentin families, and is also the following More of the diagnostic kit The improvement has laid the foundation.
- Another object of the present invention is to provide an application of a dspp mutant gene in the treatment of hereditary opalescent dentin.
- Another object of the present invention is to provide a forward primer containing a reverse primer, a reverse primer on the inner side, a reverse primer on the inner side, a reverse primer on the inner side, a 10-fold PCR reaction buffer, dNTP, Taq DNA polymerase, MgCl according to the above method.
- Restriction enzyme Rsal Restriction enzyme 10-fold reaction buffer, BSA kit.
- the invention also provides the application of the above kit in a method for detecting and treating hereditary opalescent dentin.
- the present invention links the dspp gene with hereditary opalescent dentin, and provides a new idea for the treatment of this disease.
- relevant drugs that can regulate the mineralization of the teeth were synthesized for treatment. Brief description of the drawings
- Figure 1 Family map of hereditary opalescent dentin.
- the proband in the picture is indicated by the upper left tip, and the black icon represents the affected individual.
- FIG. 1 Partial sequencing map of dspp genes from normal opalescent dentin patients with normal controls.
- the left map is a partial map of the dspp of a normal individual, and the right is a sequencing picture of the patient's mutant dspp gene.
- the eight STRPs are marked as: D4S2915, D4S2932, GATA62A11, D4S2409, DSP STRP, SPP1, D4S1563, D4S1544.
- the primer sequences of eight STRPs are shown in Table 1. PCR was performed on a Perkin Elmer 9600 thermal cycler with the above 8 pairs of primers. The reaction system was 12.5 ⁇ 1 (10 x PCR buffer 1.25 ⁇ 1, 2 mmol / L dNTPs 0.5 ⁇ ld TP (product of Sigma)).
- the PCR product can be separated from the polyacrylamide gel
- the PCR products of different sites of the same individual are mixed, and the mixed product of the 2 ⁇ reaction is taken with a molecular weight standard of 0.4 ⁇ -400, 2.1 ⁇ formamide and 0.4 ⁇ Dye mix, 95 ° (denaturation 2 11 1,); water bath quickly cooled, electrophoresis on 4% polyacrylamide and 36% urea for 2 h on Perkin Elmer ABI377 sequencer, data collection using GENESCAN 2.1 software, lane line Calibration, intrinsic molecular weight calibration and migration fragment size measurement.
- the 3581 calculates the Lod values when the recombination rates are 0, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4. Judging by the Lod value> 1, the pathogenic gene of hereditary opalescent dentin was located on chromosome 4q.
- reaction conditions are:
- the second round of PCR products was taken and directly sequenced using PCR primers as sequencing primers.
- the obtained sequence map is analyzed. Where there are impurities and double peaks, it indicates that the site is heterogeneous and needs further analysis.
- the sequences containing hetero and status sites were compared with those of Genebank and translated according to the normal reading frame. It was found that the patient had a nonsense mutation in exon III, in which the 3658th nucleotide of DSPP 3 exon was mutated from C to T, which caused the 45th position of dspp to be normally encoded by glutamine.
- the first round of PCR reaction was performed with E34fout primers. After the reaction was completed, electrophoresis and photos were archived. Then take one round of the PCR product and dilute it 250 times, and use E341out for the second round of PCR reaction.
- the reaction system is 100 ⁇ 1.
- the reaction conditions are the same as those of the mutation screening section. Take the second round of PCR products for electrophoresis and take pictures for archiving.
- PCR recovery kit is Life Technologies Concert Papid PCR Purfication System
- wash buffer containing ethanol
- centrifuge for 1 minute.
- Discard the flow-out liquid 20 ° C, ll, 900g, and centrifuge for 1 minute.
- the kit contains:
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002527304A JP3886901B2 (en) | 2000-09-15 | 2000-09-15 | Method for detecting mutant gene dspp in hereditary milky white elephant |
CNB00819646XA CN1257986C (en) | 2000-09-15 | 2000-09-15 | The method of detecting mutant DSPP gene of hereditary opalescent dentin |
DE10085485T DE10085485B4 (en) | 2000-09-15 | 2000-09-15 | Method for detecting the mutant gene dspp of hereditary opalescent dentin |
AU2000272670A AU2000272670A1 (en) | 2000-09-15 | 2000-09-15 | The method of detecting mutant dspp gene of hereditary opalescent |
PCT/CN2000/000280 WO2002022864A1 (en) | 2000-09-15 | 2000-09-15 | The method of detecting mutant dspp gene of hereditary opalescent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/CN2000/000280 WO2002022864A1 (en) | 2000-09-15 | 2000-09-15 | The method of detecting mutant dspp gene of hereditary opalescent |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002022864A1 true WO2002022864A1 (en) | 2002-03-21 |
Family
ID=4574698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2000/000280 WO2002022864A1 (en) | 2000-09-15 | 2000-09-15 | The method of detecting mutant dspp gene of hereditary opalescent |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP3886901B2 (en) |
CN (1) | CN1257986C (en) |
AU (1) | AU2000272670A1 (en) |
DE (1) | DE10085485B4 (en) |
WO (1) | WO2002022864A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323427A4 (en) * | 2000-09-05 | 2004-04-07 | Shanghai Res Ct Of Biotechnolo | Method for diagnosing and treating dentinogenesis imperfecta type ii by using dentin sialophosphoprotein (dspp) gene and its encoding product |
CN114107398A (en) * | 2020-08-27 | 2022-03-01 | 中国科学院分子细胞科学卓越创新中心 | Construction method and application of point mutation animal model of dentinogenesis imperfecta |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103233076B (en) * | 2013-05-13 | 2015-03-25 | 赤峰市农牧科学研究院 | Detection method of real-time fluorescence quantification (PCR) for DSPP (dentin sialophosphoprotein) genes in incisors of guinea pig |
WO2020235992A1 (en) * | 2019-05-21 | 2020-11-26 | Mimos Berhad | System and method to detect and quantify a dssp molecule in a sample |
-
2000
- 2000-09-15 CN CNB00819646XA patent/CN1257986C/en not_active Expired - Fee Related
- 2000-09-15 WO PCT/CN2000/000280 patent/WO2002022864A1/en active Application Filing
- 2000-09-15 JP JP2002527304A patent/JP3886901B2/en not_active Expired - Fee Related
- 2000-09-15 AU AU2000272670A patent/AU2000272670A1/en not_active Abandoned
- 2000-09-15 DE DE10085485T patent/DE10085485B4/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
CYTOGENET. CELL GENET., vol. 79, no. 1-2, 1997, pages 121 - 122 * |
EUR. J. ORAL SCI., vol. 106, no. SUPPL. 1, January 1998 (1998-01-01), pages 227 - 233 * |
J. CRANIOFAC. GENET. DEV. BIOL., vol. 17, no. 4, October 1997 (1997-10-01) - December 1997 (1997-12-01), pages 172 - 177 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1323427A4 (en) * | 2000-09-05 | 2004-04-07 | Shanghai Res Ct Of Biotechnolo | Method for diagnosing and treating dentinogenesis imperfecta type ii by using dentin sialophosphoprotein (dspp) gene and its encoding product |
CN114107398A (en) * | 2020-08-27 | 2022-03-01 | 中国科学院分子细胞科学卓越创新中心 | Construction method and application of point mutation animal model of dentinogenesis imperfecta |
CN114107398B (en) * | 2020-08-27 | 2023-11-03 | 中国科学院分子细胞科学卓越创新中心 | Construction method and application of point mutation animal model of dentin hypoplasia |
Also Published As
Publication number | Publication date |
---|---|
JP2004508067A (en) | 2004-03-18 |
JP3886901B2 (en) | 2007-02-28 |
CN1454264A (en) | 2003-11-05 |
DE10085485T1 (en) | 2003-10-16 |
AU2000272670A1 (en) | 2002-03-26 |
CN1257986C (en) | 2006-05-31 |
DE10085485B4 (en) | 2005-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bader et al. | X-linked retinitis pigmentosa: RPGR mutations in most families with definite X linkage and clustering of mutations in a short sequence stretch of exon ORF15 | |
JP2004159661A (en) | Detection of neoplasm by saliva analysis | |
AU2016351311B2 (en) | SCAP gene mutant and the application thereof | |
WO2002022864A1 (en) | The method of detecting mutant dspp gene of hereditary opalescent | |
CN114875148A (en) | Familial multiple lipoma detection kit and application of primer group | |
CN111139297B (en) | Kit for preimplantation embryo genetic diagnosis and prenatal diagnosis of DMD | |
CN111073977A (en) | Mutation detection kit for pathogenic gene SLC26A4 of vestibular aqueduct enlargement/Pendred syndrome | |
CN111321215A (en) | Congenital aniridia pathogenic gene mutation detection kit and application thereof | |
CN108866067B (en) | Pathogenic mutation of Leber congenital amaurosis and detection reagent thereof | |
CN111154883A (en) | Breast cancer related gene PIK3CA site g.179220986A & gtT mutant and application thereof | |
CN115927354B (en) | SH3TC2 gene pathogenic mutant and application thereof in preparation of fibula muscular atrophy 4C type diagnostic kit | |
CN116004799B (en) | CRTAP pathogenic mutant and application thereof in preparation of gristle syndrome VII type diagnosis kit | |
EP1352092B1 (en) | Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis | |
EP1130122A2 (en) | Methods for the diagnosis of polymorphisms in the human EP1-R gene | |
CN114622013B (en) | Juvenile idiopathic scoliosis detection product | |
CN111139301B (en) | Breast cancer related gene ERBB2 site g.39397319C > A mutant and application thereof | |
JP2000316577A (en) | Diagnosis of citrullinemia type ii onset in adult | |
CN115873861B (en) | PAH pathogenic mutant and application thereof in preparation of phenylketonuria diagnostic kit | |
CN112941186B (en) | Breast cancer susceptibility gene BRCA2-K2305N mutant and specific primer thereof | |
US7897739B2 (en) | Method for diagnosing diabetic retinopathy by single nucleotide polymorphism, DNA fragment thereof, and primer thereof | |
JP3682688B2 (en) | Osteoporosis drug sensitivity prediction method and reagent kit therefor | |
JP4219027B2 (en) | Determination method and diagnosis kit for systemic lupus erythematosus | |
CN116024333A (en) | Retinal pigment degeneration screening kit | |
CN117887828A (en) | High myopia screening kit | |
CN115850430A (en) | SCN1A mutant protein, SCN1A gene mutant, amplification primer, detection reagent and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 00819646X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002527304 Country of ref document: JP |
|
RET | De translation (de og part 6b) |
Ref document number: 10085485 Country of ref document: DE Date of ref document: 20031016 Kind code of ref document: P |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10085485 Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8607 |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8607 |